HCA Healthcare Q2 2024 Adj EPS $5.50 Beats $4.88 Estimate, Sales $17.492B Beat $17.046B Estimate
Portfolio Pulse from Benzinga Newsdesk
HCA Healthcare reported Q2 2024 adjusted EPS of $5.50, beating the $4.88 estimate, and sales of $17.492 billion, surpassing the $17.046 billion estimate. This represents a 10.28% increase in sales compared to the same period last year.
July 23, 2024 | 11:31 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HCA Healthcare's Q2 2024 earnings and sales significantly beat analyst estimates, with a notable year-over-year sales increase of 10.28%.
HCA Healthcare's strong earnings and sales performance, beating analyst estimates, is likely to positively impact the stock price in the short term. The significant year-over-year sales growth further supports a positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100